Evidence map›Paper›PMID 35234148›Full record

ArticleActa crystallographica. Section D, Structural biology2022

The suppressor of copper sensitivity protein C from Caulobacter crescentus is a trimeric disulfide isomerase that binds copper(I) with subpicomolar affinity.

Guillaume A Petit, Yaoqin Hong, Karrera Y Djoko, Andrew E Whitten, Emily J Furlong, Airlie J McCoy, Jacqueline M Gulbis, Makrina Totsika, Jennifer L Martin, Maria A Halili

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Small-angle X-ray scattering studies of enzymes.Current opinion in chemical biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guillaume A PetitGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD 4111, Australia.ORCID 0000-0002-8251-0754
Yaoqin HongCentre for Immunology and Infection Control and School of Biomedical Sciences, Queensland University of Technology, Herston, QLD 4006, Australia.ORCID 0000-0002-4408-2648
Karrera Y DjokoDepartment of Biosciences, Durham University, Durham DH1 3LE, United Kingdom.ORCID 0000-0001-9814-6515
Andrew E WhittenAustralian Nuclear Science and Technology Organization (ANSTO), New Illawarra Road, Lucas Heights, NSW 2234, Australia.ORCID 0000-0001-8856-3120
Emily J FurlongGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD 4111, Australia.ORCID 0000-0002-9086-2979
Airlie J McCoyDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom.
Jacqueline M GulbisStructural Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Makrina TotsikaCentre for Immunology and Infection Control and School of Biomedical Sciences, Queensland University of Technology, Herston, QLD 4006, Australia.ORCID 0000-0003-2468-0293
Jennifer L MartinGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD 4111, Australia.ORCID 0000-0002-9225-8863
Maria A HaliliGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD 4111, Australia.ORCID 0000-0003-4407-5269

Funding

Australian Research Council DP190101613Royal Society RSG\R1\180044
6 · The paper itself

Abstract

The introduction of disulfide bonds into periplasmic proteins is a critical process in many Gram-negative bacteria. The formation and regulation of protein disulfide bonds have been linked to the production of virulence factors. Understanding the different pathways involved in this process is important in the development of strategies to disarm pathogenic bacteria. The well characterized disulfide bond-forming (DSB) proteins play a key role by introducing or isomerizing disulfide bonds between cysteines in substrate proteins. Curiously, the suppressor of copper sensitivity C proteins (ScsCs), which are part of the bacterial copper-resistance response, share structural and functional similarities with DSB oxidase and isomerase proteins, including the presence of a catalytic thioredoxin domain. However, the oxidoreductase activity of ScsC varies with its oligomerization state, which depends on a poorly conserved N-terminal domain. Here, the structure and function of Caulobacter crescentus ScsC (CcScsC) have been characterized. It is shown that CcScsC binds copper in the copper(I) form with subpicomolar affinity and that its isomerase activity is comparable to that of Escherichia coli DsbC, the prototypical dimeric bacterial isomerase. It is also reported that CcScsC functionally complements trimeric Proteus mirabilis ScsC (PmScsC) in vivo, enabling the swarming of P. mirabilis in the presence of copper. Using mass photometry and small-angle X-ray scattering (SAXS) the protein is demonstrated to be trimeric in solution, like PmScsC, and not dimeric like EcDsbC. The crystal structure of CcScsC was also determined at a resolution of 2.6 Å, confirming the trimeric state and indicating that the trimerization results from interactions between the N-terminal α-helical domains of three CcScsC protomers. The SAXS data analysis suggested that the protomers are dynamic, like those of PmScsC, and are able to sample different conformations in solution.

Indexed as

Caulobacter crescentusProtein Disulfide-IsomerasesBacterial ProteinsCopperDisulfidesProtein CScattering, Small AngleX-Ray DiffractionBacterial ProteinsCopperDisulfidesProtein CProtein Disulfide-Isomerasescopper-binding proteinsdisulfide bond-forming proteinsprotein trimerssmall-angle X-ray scatteringsuppressor of copper sensitivity protein CX-ray crystallography

Identifiers

PMID35234148
PMCPMC8900818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.